Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.

[1]  Rongjun Chen,et al.  A Dendritic Polymer‐Based Nanosystem Mediates Drug Penetration and Irreversible Endoplasmic Reticulum Stresses in Tumor via Neighboring Effect , 2022, Advanced materials.

[2]  Fei Li,et al.  M11: A Tropism-modified Oncolytic Adenovirus Arming with Tumor-homing Peptide for Advanced Ovarian Cancer Therapies. , 2022, Human gene therapy.

[3]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[4]  G. Mills,et al.  WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway , 2021, The Journal of experimental medicine.

[5]  Lei Gu,et al.  Branched Polymer‐Based Redox/Enzyme‐Activatable Photodynamic Nanoagent to Trigger STING‐Dependent Immune Responses for Enhanced Therapeutic Effect , 2021, Advanced Functional Materials.

[6]  Lei Gu,et al.  Stimuli‐Sensitive Linear–Dendritic Block Copolymer–Drug Prodrug as a Nanoplatform for Tumor Combination Therapy , 2021, Advanced materials.

[7]  T. Yap,et al.  Targeting the replication stress response through synthetic lethal strategies in cancer medicine. , 2021, Trends in cancer.

[8]  G. Mills,et al.  EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer. , 2021 .

[9]  Xiangliang Yang,et al.  Engineering nanomedicine for glutathione depletion-augmented cancer therapy. , 2021, Chemical Society reviews.

[10]  Xiaoqi Dong,et al.  Integration of Dual Targeting and Dual Therapeutic Modules Endows Self-Assembled Nanoparticles with Anti-Tumor Growth and Metastasis Functions , 2021, International journal of nanomedicine.

[11]  Fulin Chen,et al.  Elastin-like polypeptide modified silk fibroin porous scaffold promotes osteochondral repair , 2020, Bioactive materials.

[12]  Zhuang Liu,et al.  Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics , 2020, Nano Today.

[13]  Jinjin Zhang,et al.  Cooperation therapy between anti-growth by photodynamic-AIEgens and anti-metastasis by small molecule inhibitors in ovarian cancer , 2020, Theranostics.

[14]  K. Rostamizadeh,et al.  In vivo study of poly (ethylene glycol)-poly (caprolactone)-modified folic acid nanocarriers as a pH responsive system for tumor-targeted co-delivery of tamoxifen and quercetin , 2019 .

[15]  S. Heilshorn,et al.  Rapid Diels-Alder Cross-linking of Cell Encapsulating Hydrogels. , 2019, Chemistry of materials : a publication of the American Chemical Society.

[16]  G. Mills,et al.  Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy. , 2019, Cancer cell.

[17]  Peng Huang,et al.  Mesoporous Polydopamine Carrying Manganese Carbonyl Responds to Tumor Microenvironment for Multimodal Imaging‐Guided Cancer Therapy , 2019, Advanced Functional Materials.

[18]  Jing Wang,et al.  Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. , 2019, Cancer discovery.

[19]  J. Schlenoff,et al.  Engineering Thiolated Surfaces with Polyelectrolyte Multilayers. , 2019, ACS applied materials & interfaces.

[20]  Yaou Duan,et al.  Application of polydopamine in tumor targeted drug delivery system and its drug release behavior. , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J. Jalaei,et al.  Antibacterial effects of gold nanoparticles functionalized with the extracted peptide from Vespa orientalis wasp venom , 2018, Journal of peptide science : an official publication of the European Peptide Society.

[22]  G. Mills,et al.  State-of-the-art strategies for targeting the DNA damage response in cancer , 2018, Nature Reviews Clinical Oncology.

[23]  Gabe S. Sonke,et al.  Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer , 2018, The New England journal of medicine.

[24]  L. Shen,et al.  Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint , 2018, Journal of experimental & clinical cancer research : CR.

[25]  Crispin J. Miller,et al.  The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer , 2018, Clinical Cancer Research.

[26]  R. Mrówczyński.  Polydopamine-Based Multifunctional (Nano)materials for Cancer Therapy. , 2017, ACS applied materials & interfaces.

[27]  S. Loi,et al.  Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. , 2017, The New England journal of medicine.

[28]  T. Lawrence,et al.  PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors , 2017, Molecular Cancer Research.

[29]  H. K. Manjili,et al.  Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin , 2017, Drug Research.

[30]  Feng Chen,et al.  Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy. , 2017, Nanoscale.

[31]  A. Ashworth,et al.  Modeling Therapy Resistance in BRCA1/2-Mutant Cancers , 2017, Molecular Cancer Therapeutics.

[32]  J. Schellens,et al.  Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer , 2017, Clinical Cancer Research.

[33]  W. Haas,et al.  Coupling of Homologous Recombination and the Checkpoint by ATR. , 2017, Molecular cell.

[34]  Mark Morgan,et al.  Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models , 2016, Clinical Cancer Research.

[35]  A. Oza,et al.  Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  G. Mills,et al.  Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics , 2016, Clinical Cancer Research.

[37]  X. Lou,et al.  Formation of Asymmetric Bowl-Like Mesoporous Particles via Emulsion-Induced Interface Anisotropic Assembly. , 2016, Journal of the American Chemical Society.

[38]  B. Karlan,et al.  Characteristics of 10-year survivors of high-grade serous ovarian carcinoma. , 2016, Gynecologic oncology.

[39]  Feng Chen,et al.  Silica-assisted incorporation of polydopamine into the framework of porous nanocarriers by a facile one-pot synthesis. , 2016, Journal of materials chemistry. B.

[40]  Jianru Xiao,et al.  Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation. , 2016, Biomaterials.

[41]  K. Cai,et al.  Polydopamine Coatings in Confined Nanopore Space: Toward Improved Retention and Release of Hydrophilic Cargo , 2015 .

[42]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[43]  Wei Huang,et al.  Engineering Melanin Nanoparticles as an Efficient Drug–Delivery System for Imaging‐Guided Chemotherapy , 2015, Advanced materials.

[44]  Karen D. Cowden Dahl,et al.  In vivo tumor growth of high-grade serous ovarian cancer cell lines. , 2015, Gynecologic oncology.

[45]  Peter Gibbs,et al.  Early detection of cancer: past, present, and future. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[46]  Huimao Zhang,et al.  Facile Preparation of Doxorubicin‐Loaded Upconversion@Polydopamine Nanoplatforms for Simultaneous In Vivo Multimodality Imaging and Chemophotothermal Synergistic Therapy , 2015, Advanced healthcare materials.

[47]  Homan Kang,et al.  Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes. , 2015, Biomaterials.

[48]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[49]  N. Peppas,et al.  Intelligent Nanoparticles for Advanced Drug Delivery in Cancer Treatment. , 2015, Current opinion in chemical engineering.

[50]  V. A. Flørenes,et al.  Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. , 2014, Gynecologic oncology.

[51]  D. Levine,et al.  New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair , 2014, Molecular Cancer Therapeutics.

[52]  Lehui Lu,et al.  Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. , 2014, Chemical reviews.

[53]  J. Ljubimova,et al.  Nanomedicine therapeutic approaches to overcome cancer drug resistance. , 2013, Advanced drug delivery reviews.

[54]  Jian Ji,et al.  Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. , 2013, ACS nano.

[55]  Won Jong Kim,et al.  Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. , 2013, ACS nano.

[56]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[57]  Andreas Wicki,et al.  Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. , 2012, The Lancet. Oncology.

[58]  Tsuyoshi Arai,et al.  Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents , 2009, Molecular Cancer Therapeutics.

[59]  R. Chen,et al.  TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis , 2008, Clinical Cancer Research.

[60]  Lei Tao,et al.  Design and synthesis of N-maleimido-functionalized hydrophilic polymers via copper-mediated living radical polymerization: a suitable alternative to PEGylation chemistry. , 2005, Journal of the American Chemical Society.

[61]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.